Healthcare Webinars

Sponsored by MGRI Division of Clinical Research and Harvard Center for Bioethics Title: Ethical Considerations of Access to Investigational Medicines Speaker: Karla G. Childers, BA, MSJ, MSBE, Head, Bioethics-based Science & Technology Policy, Office of the Chief Medical Officer, Johnson & Johnson

Sarcoma Foundation of America is dedicated to fostering the development of innovative treatment options for those affected by sarcoma. In collaboration with the esteemed CDRC Sarcoma Task Force, we are excited to present a pioneering project that delves into the potential of repurposing existing medications for the benefit of sarcoma patients. This initiative is at the forefront of leveraging real-world data—from electronic medical records to invaluable insights shared by patients and their healthcare providers. The goal is to illuminate the path to cost-effective treatments, harnessing the power of existing drugs that, while proven safe, require further evidence to support their novel application in sarcoma therapy. Your involvement is crucial in propelling this research forward, paving the way for new, accessible treatment avenues for the sarcoma community.

The evolving landscape of immune-oncology and cancer therapy research is being profoundly reshaped by single-cell RNA sequencing technologies. Join this webinar to discover the significance of single-cell omics profiling in oncological research, unraveling tumor microenvironment complexities post-immune therapies using single-cell RNA sequencing, and detailed analysis of transcriptional changes in specific cell types under various conditions.

Discover an informative webinar delving into DNA-encoded library (DEL) technology in drug discovery, showcasing tailored campaigns, parallel screening and innovative hit identification for challenging targets.

Asim Shabbir: “How and why lowering of BMI thresholds and a move from BMI to clinical indications matters in the APC” Mark Magdy: “The impact of medications (as alternatives and adjuncts to surgery) and expected uptake in APC” Ahmad Aly: “What the global congress coming to the APC in 2024 can offer and a preview”

The COVID-19 pandemic prompted a rapid shift towards digital health solutions to address healthcare challenges, offering virtual access to a range of services including contact tracing, public health updates, virtual care, mental health support, and vaccine booking. While digital technologies helped mitigate virus spread, their unintended impact on health equity, particularly for marginalized racialized low-income communities, emerged as a parallel concern. This research investigates the influence of digital health adoption on pre-existing inequities among racialized Ontarians, utilizing a qualitative literature review. The study examines healthcare structures, socio-economic factors, and assesses the 2019 Digital First for Health Strategy's impact on health equity. COVID-19 policies and digital tools are analyzed for their effect on racialized populations, revealing existing gaps. Despite public funding, Ontario's healthcare system remains unequal, disproportionately affecting racialized communities during the pandemic due to discriminatory policies and inaccessible digital solutions. Pre-pandemic analysis confirms long-standing health inequities, with socio-economic factors driving 50% of health outcomes. Low income's domino effect worsens health outcomes for vulnerable individuals, including hindrances to accessing virtual care. Addressing this, the study advocates for evidence-based policies, among other recommendations that are rooted in equity. Presented by: Ishaw Sharma is an Indo-Canadian healthcare professional residing in Toronto with over a decade of experience in clinical research, public health, and digital health. With a background encompassing a BSc in Life Sciences and an MBA, her commitment extends to shaping an inclusive digital healthcare system in Ontario and beyond. Ishaw also dedicates herself to advancing her academic research on current digital health and its implications on pre-existing health disparities in Ontario for racialized population. She actively advocates for equitable policies through public forums and documentary photography.

Wednesday, January 17, 18:00 CET Cystic pancreatic neoplasms: MDT Speaker: Giuseppe Malleo, Verona/IT & Giulia Zamboni, Verona/IT Moderator: Alessandra Borgheresi, Ancona/IT General description, scope and objectives of this webinar: The programme of this webinar will cover imaging features and treatment of cystic pancreatic lesions. It is aimed at oncologic imaging radiologists, radiologist residents/juniors, students and people who want to improve their skills in: - Characterization and differential diagnosis of pancreatic cystic lesions - Recognizing malignant or premalignant lesions After watching the webinar, participants will be able to: - Characterize pancreatic cystic lesions at US and cross-sectional imaging (MR, CT) - Define the next step to recommend to patients (further imaging, surgical consultation, follow-up) This webinar is open to all interested persons. We are pleased to inform you that all webinars 2024 have been granted 1 European CME credit (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®). More information: https://www.esoi-society.org/webinars/ Please click here to read the full Bracco Information and consent form: https://www.esoi-society.org/app/uploads/BRACCO-information-and-consent-form.docx

The MRCT Center and Medable created a task-force to tackle the ethical and regulatory challenges of Decentralized Clinical Trials (DCTs). Join this webinar to learn about the tools and guidelines developed by Medable and MRCT for ethical review of DCTs. The webinar will cover topics like eConsent, recruitment and remote visits, privacy and security concerns, and issues related to devices used in DCTs.

In this webinar we would like to discuss the challenges and opportunities for being involved in conducting ethical analyses at HTA agencies. Bart Bloemen, co-chair of the IG on ethics, will present the work that the interest group is currently conducting on a paper that addresses this topic. Following this introduction, two speakers will present their experiences with working as an ethicist at HTA institutes. Renata Axler leads the development of ethics methodologies and practices at the Canadian Agency for Drugs and Technologies in Health (CADTH). Lars Sandman is professor at Linköping University, and also assigned as ethics advisor for Swedish health care authorities and director at the National Centre for Priorities in Health. Both will present examples of their work, and reflect upon the lessons they have learned with respect to being involved in ethical analyses in this context. These presentations will be the basis and an invitation to the audience for exchanging ideas about how to advance this interesting area of HTA.

Discover an informative webinar delving into site enablement strategies for ensuring clinical research success. It has become crucial for clinical research sponsors and contract research organizations (CROs) to understand and implement a site enablement strategy in an era where clinical research sites are in high demand. This webinar isn’t just a learning opportunity; it’s a crucial strategy session for those looking to succeed in the next era of connected research. The featured speakers will explore five key areas of site enablement that are crucial for building relationships with sites, ensuring adequate participation in studies, and ensuring the success of research. The webinar will provide practical, actionable strategies that can make the difference between leading and lagging in the industry. The seasoned experts will also share real-world success stories. Site enablement narratives will demonstrate how effective strategies can streamline operations, mitigate risks, and enhance site capacity. In the coming year, missing these insights could mean bypassing crucial tactics that will make or break success. Specifically, the Site Enablement Maturity Assessment will be discussed. Besides being informative, this tool is essential for evaluating current strategies and identifying areas for improvement. Each attendee will receive a free copy, providing a unique opportunity to benchmark organizations. This webinar showcases a team experienced in optimizing operational workflows across 18,000 global sites. They’ve also offered support to various sponsors in developing site enablement strategies, providing valuable insights and expertise. As we step into 2024, the strategies adopted today play a vital role in organizational success. Join this webinar to learn insights into clinical site enablement and tools to navigate the landscape of clinical research.